| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -41.6% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 2.0 | n/a |
| Pr/Book | 3.2 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 37.4% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Jun-21 | 11.62 | (6.95) | (1.25)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-22 | 2.84 | (21.59) | (3.43)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-23 | 4.05 | (3.57) | (0.94)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-24 | 6.14 | (1.40) | (0.37)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-25 | 8.43 | (3.50) | (0.71)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Trading on the OTCQB Venture Market in the US | 10-Mar-2026 | 07:00 | RNS |
| Exercise of options and total voting rights | 29-Dec-2025 | 14:35 | RNS |
| Abingdon Health lands £4.8m lateral‑flow d... | 30-Mar-2026 | ShareCast |
| Trading on the OTCQB Venture Market in the US | 10-Mar-2026 | ShareCast |
| Exercise of options and total voting rights | 29-Dec-2025 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 9.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 9.50 |
| 52 Week Low | 5.25 |
| Volume | 15,446 |
| Shares Issued | 251.08m |
| Market Cap | £22.60m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:56 | 2,109 @ 9.48p |
| 14:12 | 2,934 @ 9.50p |
| 12:18 | 2,140 @ 8.90p |
| 10:07 | 526 @ 9.50p |
| 10:00 | 34 @ 9.50p |
You are here: research